Roche (ROG) Receives Buy Rating from JPMorgan Chase & Co.
ROG has been the subject of a number of other research reports. Goldman Sachs Group set a CHF 325 price objective on Roche and gave the company a buy rating in a research note on Thursday, October 12th. Morgan Stanley set a CHF 260 price objective on Roche and gave the company a neutral rating in a research note on Friday, November 17th. Deutsche Bank set a CHF 264 price objective on Roche and gave the company a neutral rating in a research note on Tuesday, December 12th. Liberum Capital set a CHF 279 price objective on Roche and gave the company a buy rating in a research note on Wednesday, November 22nd. Finally, Baader Bank set a CHF 231 price objective on Roche and gave the company a neutral rating in a research note on Thursday, October 19th. Three analysts have rated the stock with a sell rating, eight have assigned a hold rating and nine have issued a buy rating to the stock. The stock currently has an average rating of Hold and a consensus target price of CHF 263.42.
Shares of Roche (VTX ROG) traded up CHF 1.30 during trading on Thursday, reaching CHF 245.80. The company’s stock had a trading volume of 1,680,000 shares, compared to its average volume of 1,550,000. Roche has a 12-month low of CHF 226.10 and a 12-month high of CHF 273. The firm has a market capitalization of $212,060.00 and a PE ratio of 21.85.
Roche Company Profile
Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.
Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.